Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimon Shteingart

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Digestive Diseases and Sciences|August 31, 2016
Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II TrialIris Dotan, Etgar Levy-Nissenbaum, Yehuda Chowers, et al.
Digestive Diseases and Sciences|February 15, 2016
The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic ImplicationsTomer Adar, Shimon Shteingart, Ami Ben-Ya'acov, et al.
World Journal of Hepatology|July 27, 2016
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case reportYaakov Hasin, Shimon Shteingart, Harel Dahari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 25, 2014
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kineticsHarel Dahari, Shimon Shteingart, Inna Gafanovich, et al.
Digestive Diseases and Sciences|July 21, 2018
Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel DiseaseAriella Bar-Gil Shitrit, Chen Chen-Shuali, Tomer Adar, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Digestive Diseases and Sciences|August 31, 2016
Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II TrialIris Dotan, Etgar Levy-Nissenbaum, Yehuda Chowers, et al.
Digestive Diseases and Sciences|February 15, 2016
The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic ImplicationsTomer Adar, Shimon Shteingart, Ami Ben-Ya'acov, et al.
World Journal of Hepatology|July 27, 2016
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case reportYaakov Hasin, Shimon Shteingart, Harel Dahari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 25, 2014
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kineticsHarel Dahari, Shimon Shteingart, Inna Gafanovich, et al.
Digestive Diseases and Sciences|July 21, 2018
Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel DiseaseAriella Bar-Gil Shitrit, Chen Chen-Shuali, Tomer Adar, et al.
Pageof 2